2026. A Review on Application of Zebrafish Disease Models, Neurobehavioral Phenotyping, and Biochemical Markers in Preclinical Screening for Alzheimer’s Disease: Review Article. Journal of Pharma Insights and Research. 4, 4 (Aug. 2026), 046–056. DOI:https://doi.org/10.69613/fvpav364.